Anixa Advances Breast Cancer Vaccine to Phase 2 Trial
SAN JOSE, Calif., USA — April 1, 2026 In a significant advancement in cancer immunotherapy and clinical-stage biotechnology innovation,...
AI in Healthcare Alzheimer’s Disease Bio-Pharma biologics biopharma biopharma innovation Biotechnology cancer therapy Cell Therapy cGxP Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development FDA fda approval FDA clearance GCP Gene Therapy GMP GMP compliance Immuno-Oncology immunology Immunotherapy Medical Devices MedTech medtech innovation Monoclonal Antibody Oncology oncology innovation Orphan Drug orphan drug designation patient access Phase 2 Trial Phase 3 trial Precision Medicine Precision Oncology rare disease rare diseases Regenerative Medicine regulatory approval regulatory compliance targeted therapy
SAN JOSE, Calif., USA — April 1, 2026 In a significant advancement in cancer immunotherapy and clinical-stage biotechnology innovation,...
NEW YORK | December 31, 2025 — Intelligent Bio Solutions announced a strategic manufacturing partnership with Syrma Johari MedTech,...
Florham Park, New Jersey | December 22, 2025 — Celularity Inc., a regenerative and cellular medicine company focused on...
Los Angeles, California, November 10, 2025 — Armata Pharmaceuticals, Inc., a clinical-stage biotechnology company pioneering bacteriophage (phage) therapeutics targeting...
San Diego, CA – September 23, 2025 — Gallant, an animal-health biotechnology company specializing in regenerative medicine, announced that...
OKLAHOMA CITY, Sept. 17, 2025 – Wheeler Bio, Inc., a U.S.-based contract development and manufacturing organization (CDMO), announced today...
Andelyn Biosciences, a leading cell and gene therapy CDMO, has partnered with Tern Therapeutics to perform late-stage Process Performance...
